lacZTransgenic Rats Tolerant forβ-Galactosidase: Recipients for Gene Transfer Studies UsinglacZas a Reporter Gene
- 20 July 2002
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 13 (11) , 1383-1390
- https://doi.org/10.1089/104303402760128603
Abstract
Gene transfer of reporter genes may trigger immune responses against the heterologous protein resulting in shortening of gene expression and inflammation. We generated transgenic rats expressing the lacZ gene under the control of the human immunodeficiency virus type 1 (HIV-1) long-terminal repeat (LTR) (HIV-lacZ) to obtain rats with undetectable transgene expression using histologic methods, thus avoiding interference with β-galactosidase (β-gal) expression from gene transfer, and displaying immune tolerance toward β-gal. LacZ transgenic mice with tolerance toward β-gal have already been used for gene transfer but rats constitute unique animal models with several advantages compared to mice. Two transgenic lines displayed low levels of β-gal mRNA in most organs tested, as detected only by reverse transcription-polymerase chain reaction (RT-PCR). The protein was undetectable by immunohistology and was only detected in the thymus and spleen using a sensitive enzyme-linked immunosorbent assay (ELISA). HIV-lacZ transgenic rats displayed immune tolerance to β-gal because immunization with β-gal resulted in markedly lower cellular and antibody responses compared to wild-type controls, whereas immunization with a nonrelated antigen, keyhole limpet hemocyanin (KLH), resulted in comparable immune responses. The usefulness of this model in gene transfer was tested using a retroviral vector, which does not elicit destructive immune responses against transduced cells. Retroviral-mediated nlslacZ gene transfer in the liver resulted in nuclear β-gal expression for longer than 12 months in HIV-lacZ transgenic rats, whereas wild-type controls showed nuclear β-gal expression for less than 1 month. After gene transfer of nlslacZ to the liver, antibodies, cytotoxic T lymphocytes (CTLs), and proliferation against β-gal were detected in wild-type controls but not in HIV-lacZ transgenic rats. In conclusion, HIV-lacZ transgenic rats displaying low β-gal expression and immune tolerance toward β-gal are a useful tool to analyze the spatial and temporal expression of the β-gal protein in gene transfer experiments using lacZ as a reporter gene.Keywords
This publication has 32 references indexed in Scilit:
- Cytotoxic Immune Response Blunts Long-Term Transgene Expression after Efficient Retroviral-Mediated Hepatic Gene Transfer in RatMolecular Therapy, 2002
- Green Fluorescent Protein-Transgenic Rat: A Tool for Organ Transplantation ResearchBiochemical and Biophysical Research Communications, 2001
- Renal Tubule-specific Transcription and Chromosomal Localization of Rat Thiazide-sensitive Na-Cl Cotransporter GenePublished by Elsevier ,2001
- Successful Interference with Cellular Immune Responses to Immunogenic Proteins Encoded by Recombinant Viral VectorsJournal of Virology, 2001
- In VivoRetrovirus-Mediated Gene Transfer to the Liver of Dogs Results in Transient Expression and Induction of a Cytotoxic Immune ResponseHuman Gene Therapy, 1999
- Anti-Adenovirus Immune Responses in Rats Are Enhanced by Interleukin 4 but Not Interleukin 10 Produced by Recombinant AdenovirusHuman Gene Therapy, 1998
- Transgenesis in rats: Technical aspects and modelsTransgenic Research, 1996
- Long‐term humoral and cellular immunity induced by a single immunization with replication‐defective adenovirus recombinant vectorEuropean Journal of Immunology, 1995
- In vivo activation by ultraviolet rays of the human immunodeficiency virus type 1 long terminal repeat.Journal of Clinical Investigation, 1990
- The Rat as an Experimental AnimalScience, 1989